fo r info CTRV Forging Higher Over Past 6-Mo

Quote:

---

Investors ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) are heading into the 3rd quarter of this year on a positive note as the stock provided some gains of 71.93% over the past 6 months. More recently the stock is 63.33% over the past 5 trading days. Looking a bit further out the stock is 63.33% for the month and 84.91% for the quarter.

Session Update

At the session level, shares of ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) moved 35.17% from the open. The most recent bid on the stock was registered at $1.96. Further, company shares have been seen trading -30.50% off of the 52 week high and 157.89% away from the 52 week low. Narrowing in further, the stock has been recently noted at 29.80% away from the 50 day high and 106.32% separated from the 50 day low.

Analyst Views

Wall Street brokerage firms that regularly cover the stock have provided price targets and recommendations on ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV). According to First Call, the consensus price target for the company is $5.00. The consensus recommendation provided by analysts is currently 2.00. This number is based on a scale from 1 to 5. Analysts rating the company a 1 or 2 indicate a Buy recommendation. Analysts rating the company a 4 or 5 indicate a Sell recommendation. Analysts rating the company a 3 indicate a Hold recommendation.

---